期刊文献+

N末端B型利钠肽前体和高敏C反应蛋白对行直接经皮冠状动脉介入治疗的急性心肌梗死患者近期预后的预测价值 被引量:3

N-terminal pro-brain natriuretic peptide and high sensitivity C-reactive protein in assessing prognosis of patients with acute myocardial infarction after primary percutaneous coronary intervention
下载PDF
导出
摘要 目的探讨N末端B型利钠肽前体(NT-proBNP)、高敏C反应蛋白(hs-CRP)对行直接经皮冠状动脉介入治疗(PCI)的急性心肌梗死(AMI)患者术后近期预后的预测价值。方法入选行直接PCI术的AMI患者61例,于术后2周测定血浆NT-proBNP和hs-CRP水平,PCI术后3d、3个月行超声心动图检查。观察住院期间及PCI术后3个月内心血管事件发生情况。结果左心室重塑组[左心室舒张末期容积指数增加率(ΔLVEDVI)≥20%]的NT-proBNP、hs-CRP水平均显著高于无左心室重塑组(ΔLVEDVI<20%,P值均<0.05),有心血管事件组的NT-proBNP、hs-CRP水平均显著高于无心血管事件组(P值均<0.05)。结论血浆NT-proBNP和hs-CRP水平对行直接PCI术后的AMI患者术后近期预后有一定的预测作用。 Objective To investigate the roles of plasma N-terminal pro-brain natriuretic(NT-proBNP)and high sensitivity C-reactive protein(hs-CRP)in assessing the prognosis of patients with acute myocardial infarction(AMI)after primary percutaneous coronary intervention(PCI).Methods A total of 61 AMI patients receiving primary PCI were included in the present study.The plasma NT-proBNP and hs-CRP were measured within two weeks after primary PCI and the echocardiograms were taken at 3 days and 3 months after PCI.The vascular events were observed during hospitalization and within 3 months after PCI.Results The plasma NT-proBNP and hs-CRP levels were significantly higher in left ventricular remodeling group(left ventricular ejection fraction [ΔLVEDVI]≥20%)compared with those in left ventricular non-remodeling group(ΔLVEDVI20%,both P0.05).And NT-proBNP and hs-CRP levels were significantly higher in the group with post-PCI cardiac events compared with those in the event free group(both P0.05).Conclusion Plasma NT-proBNP and hs-CRP levels can be used to predict the prognosis of AMI patients after primary PCI.
出处 《上海医学》 CAS CSCD 北大核心 2010年第10期927-929,共3页 Shanghai Medical Journal
关键词 N末端B型利钠肽前体 高敏C反应蛋白 直接经皮冠状动脉介入治疗 N-terminal pro-brain natriuretic High sensitivity C-reactive protein Primary percutaneous coronary intervention
  • 相关文献

参考文献11

  • 1高伟,王士雯,赵玉生.脑钠肽前体N末端片段在心血管病研究应用中的现状[J].中华心血管病杂志,2004,32(8):759-761. 被引量:65
  • 2Zhang G X,Zhang X F,Chen B,et al.Tel index and b-type natriuretic peptide in assessment of high-risk patients with acute coronary artery syndromes.J H K coll cardiol,2009,17:4-10.
  • 3Burazor I,Burazor M,Dimic D,et al.C-reactive protein,inflammation and lipid as risk factors for coronary artery disease and myocardial infarction//Lewis B S,Halon D A,Flugelman M Y,et al.Frontiers in Coronary Artery Disease.Bologna:Monduzzi Editore,2003:67-70.
  • 4Ndrepepa G,Braun S,Mehilli J,et al.N-terminal pro-brain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with seintigraphic infarct size,efficacy of reperfusion,and prognosis.Am J Cardiol,2006,97:1151-1156.
  • 5郑宏,朱福音,张丽莉,李艳华,赵学森.介入治疗对急性心梗患者血浆脑钠肽水平的影响[J].中国现代医药杂志,2008,10(2):49-50. 被引量:3
  • 6陈雯艾,刘海波,陈君柱,姜昌浩,陈智理,吴荣辉,何晓清.不同再灌注情况首次急性前壁ST段抬高心肌梗死者血浆脑钠肽和左室重构的变化[J].中国医刊,2008,43(10):35-37. 被引量:6
  • 7Nagaya N,Nishikimi T,Goto Y,et al.Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction.Am Heart J,1998,135:21-28.
  • 8Scirica B M,Cannon C P,Sabatine M S,et al.Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death.Clin Chem,2009,55:265-273.
  • 9Tang W H,Steinhubl S R.Van Lente F,et al.Risk stratification for patients undergoing nonurgent pereutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide:a Clopidogrel for the Reduction of Events During Observation(CREDO)substudy.Am Heart J,2007,153:36-41.
  • 10deLemos J A,Morrow D A,Bentley J H,et al.The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.N Engl J Med,2001,345:1014-1021.

二级参考文献31

  • 1杨海波,唐元升,朱兴雷,黄振文.再灌注治疗对急性心肌梗死患者血浆脑钠尿肽和左心室重塑的影响[J].中国动脉硬化杂志,2004,12(6):687-690. 被引量:1
  • 2杨新春,郭军,王乐丰,程祖亨,葛永贵,王红石,佟子川,邹阳春,王立忠,李惟铭,徐立,连勇.急性ST段抬高心肌梗死直接经皮冠状动脉介入术冠状动脉无复流患者的左室功能[J].中国介入心脏病学杂志,2004,12(4):218-221. 被引量:4
  • 3李瑞杰,彭夫松,胡江乔,黄轶峰,卢全,任文林,李莉.血清脑钠肽水平变化在ST段不抬高急性冠状动脉综合征中的临床意义[J].中国医药导刊,2004,6(6):407-408. 被引量:3
  • 4[1]Sudoh T,K,Minamino N,Matsuo H.A New natriuretic peptide in procine brain.Nature,1988,332(6159):78-81
  • 5[2]Motwani JG,Mcalpine H,Kennedy N,et al.Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.Lancet,1993,341:(1)109-113
  • 6[3]Ikeda T,Mastsuda k,Itoh H,et al.Plasma leves of brain and atrial natri uretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis.Am Heart J,1997,133(3):307-314
  • 7[4]Mccullough PA.Clinical applications of B-type natfiuretic peptide levels in the care of cardiovascular patients.Minerva Car dioangiol,2004,52(6):479-489
  • 8[5]Sndoh T,Kangawa K,M inam ino N,et al.A natriuretic peptide in porcine brain.Nature,1998,332(3):78-81
  • 9[7]Morita E,Yasue H,Yoshimura M,Ogawa H,et al.Incresaed plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.Circulation,1993,88(1):82-91
  • 10[8]Nagaya N,Nishikimi T,Goto Y,et al.Plasma brain natriuretic pepride is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction.Am Heart J,1998,135(1):21-28

共引文献71

同被引文献26

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部